The Kenya Ministry of Public Health on Saturday will launch a $1.8 million measles vaccination campaign targeting “1.3 million children who have not been vaccinated against the disease since July 2006,” Business Daily Africa reports. “Measles has become a major public concern in the country and in northern Kenya refugee camps in particular,” as the government has found itself “unable to screen refugees flooding into the country through Kenyaâ€™s porous northern border,” the newspaper writes.
A group of nine countries on Thursday announced they would share H1N1 (swine flu) vaccine supplies with developing nations to protect the world’s poorest from the H1N1 virus, Reuters reports. The U.S. joined Australia, Brazil, France, Italy, New Zealand, Norway, Switzerland, and Britain in the pledge, according to the news service. The new donations add to the 120 million vaccine doses pharmaceutical companies GlaxoSmithKline and Sanofi-Pasteur pledged to WHO.
Merck, Wellcome Trust To Launch Vaccine Center In India To Produce Vaccines For Developing Countries
The pharmaceutical company Merck and the Wellcome Trust have joined together to create a non-profit, Â£90-million (about $150 million) research center in India to facilitate the development of new vaccines, “including [those for] neglected diseases for which inadequate or no vaccines exist,” Nature News reports.
The recent news that a single dose of H1N1 (swine flu) vaccine can protect adults against the virus has sparked conversations between the WHO and developed countries about sharing their vaccine stockpiles with developing countries, Bloomberg reports.
HHS Secretary Kathleen Sebelius announced Tuesday during a House Energy and Commerce Committee hearing that H1N1 (swine flu) vaccines produced by four manufacturers — CSL Ltd., Novartis, Sanofi-Pasteur and Medimmune — had won FDA approval, paving the way for a U.S. large-scale vaccination campaign, the Wall Street Journal reports. The application for GlaxoSmithKline PLC’s vaccine is still being considered.
Recent findings that a single dose of an H1N1 (swine) flu vaccine offers protection against the virus and anticipation of vaccination programs starting earlier than predicted will increase the number of people worldwide with access to the vaccine and the likelihood health officials may be able to control the spread of the virus, Bloomberg reports.
Health and Human Services Secretary Kathleen Sebelius said on Sunday that the H1N1 (swine) flu vaccine will be available in the U.S. earlier than previously anticipated, the Wall Street Journal reports.
The results of clinical trials have shown one dose of the H1N1 (swine) flu vaccine is enough to offer adults protection against the virus, U.S. and Australian researchers said Thursday, the Associated Press reports.
“Each year 1.2 million children under age 5 die from Streptococcus pneumoniae and Haemophilus influenzae B or Hib,” which cause pneumococcal disease and are preventable with vaccines, according to studies published Thursday in the journal Lancet, Reuters reports.
Despite progress in raising the vaccination rates in the world’s poorest countries, some countries, including India, the Democratic Republic of Congo, Nigeria, Ethiopia and Indonesia, continue to have vaccination rates “below 50% in certain regions, compared with the 80% or more needed to achieve a low risk of the disease spreading,” Douglas Holt, Oxford University professor of marketing, and Jacob McKnight, also of Oxford University, write in a Livemint.com analysis piece.